Pentedrone, also known as 4-MEAP and 4-MEAPP, is a stimulant drug of the cathinone class and has emerged on the illicit drug market as a designer drug. 4-MEAP has been found to be incorrectly sold as 4-methylpentedrone. This Certified Spiking Solution; is suitable as starting material in calibrators and controls for GC/MS or LC/MS testing applications in forensic analysis, urine drug testing or clinical toxicology.



Pentedrone (also known as α-methylamino-valerophenone) is a stimulant of the cathinone class that has been sold as a designer drug and has been found since 2010 as an ingredient in a number of “bath salt” mixes sold as legal highs.

This is a case report of a fatal intoxication in Cyprus related to 3,4-methylenedioxypyrovalerone (MDPV) and 2-(methylamino)-1-phenylpentan-1-one (pentedrone) intake combined with antipsychotic and antidepressant substances. A 42- year old man with a history of serious psychiatric illness was found unresponsive in his bed. Seized materials were also found close to his body. The forensic autopsy reported myocardial infarction due to multidrug intoxication. Toxicology screening in blood and urine was applied. Biological specimens were analysed by enzyme immunoassay procedure and GC/MS. MDPV, pentedrone and etizolam detected and quantitated in blood and urine. Other drugs quantitated in blood were also olanzapine, mirtazapine, and ephedrine. This was the first fatal case reported in Cyprus associated with new psychoactive substances. Additionally, this was the first case reported to Early Warning System of the European Monitoring Center of Drugs and Drug Abuse (EMCDDA), related to multidrug intoxication, attributed to the consumption of cathinones, designer benzodiazepines, and other drugs.

Additional information


10 g, 100 g, 1000 g, 25 g, 250 g, 50 g, 500 g